Modified Release Hydrocortisone (Plenadren®)

Rapid Review

Assessment Status Assessment process complete
Rapid review commissioned 09/08/2013
Rapid review completed 17/09/2013
Rapid Review Outcome Full Pharmacoeconomic Evaluation not recommended
 A new application for reimbursement was made to the HSE and a rapid review was commissioned in November 2017.
Assessment Status Assessment process complete
Drug Modified Release Hydrocortisone
Brand Plenadren®
Indication For the treatment of adrenal insufficiency in adults.
Assessment Process
Rapid review commissioned 08/11/2017
Rapid review completed 11/01/2018
Rapid review outcome Reimbursement not recommended at the submitted price.